Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
語言
全文檢索
題名
作者
主題
索引號
ISBN/ISSN
標簽
檢索
高級檢索
The novel ATR inhibitor VE-821...
引用
發送短信
推薦此
打印
導出紀錄
導出到 RefWorks
導出到 EndNoteWeb
導出到 EndNote
Permanent link
The novel ATR inhibitor VE-821 selectively sensitizes pancreatic cancer cells to radiation and chemotherapy
書目詳細資料
Main Authors:
Fokas, E
,
Prevo, R
,
Reaper, P
,
Charlton, P
,
Pollard, J
,
Mckenna, W
,
Muschel, R
,
Brunner, T
格式:
Conference item
出版:
2012
持有資料
實物特徵
相似書籍
職員瀏覽
實物特徵
總結:
相似書籍
The novel ATR inhibitor VE-821 increases sensitivity of pancreatic cancer cells to radiation and chemotherapy.
由: Prevo, R, et al.
出版: (2012)
ATR targeting by the novel inhibitor VE-822 selectively sensitizes pancreatic cancer cells and tumors to radiation and chemoradiation
由: Fokas, E, et al.
出版: (2013)
Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation.
由: Fokas, E, et al.
出版: (2012)
Targeting ATR in DNA damage response and cancer therapeutics.
由: Fokas, E, et al.
出版: (2014)
Targeting ATR in DNA damage response and cancer therapeutics
由: Fokas, E, et al.
出版: (2014)